Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02422615
Title Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. (MONALEESA-3)
Acronym MONALEESA-3
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
Southern Cancer Center PC SC-2 Mobile Alabama 36608 United States Details
Ironwood Cancer and Research Centers SC-2 Chandler Arizona 85224 United States Details
Highlands Oncology Group . Fayetteville Arkansas 72703 United States Details
UCLA Medical Center . Los Angeles California 90095 United States Details
Central Coast Medical Oncology Corporation SC Santa Maria California 93454 United States Details
St Joseph Heritage Healthcare Santa Rosa California 94503 United States Details
Poudre Valley Hospital Fort Collins Colorado 80528 United States Details
Florida Cancer Research Institute Dept of Oncology Davie Florida 33328 United States Details
Florida Hospital Cancer Institute SC Orlando Florida 32804 United States Details
UF Health Cancer Center at Orlando Health Orlando Florida 32806 United States Details
John D Archbold Memorial Hospital Main Thomasville Georgia 31792 United States Details
Moanalua Medical Center. Attn: Oncology Dept SC Honolulu Hawaii 96817 United States Details
Oncology Specialists, SC Advocate Medical Group-Niles Park Ridge Illinois 60068-0736 United States Details
Jackson Oncology Associates SC Jackson Mississippi 39202 United States Details
Meridian Health Systems Regulatory Neptune New Jersey 07753 United States Details
University of New Mexico Cancer Center SC Albuquerque New Mexico 87131 United States Details
CR Wood Cancer Center SC Glens Falls New York 12801 United States Details
Clinical Research Alliance . Lake Success New York 11042 United States Details
NYU Langone Med Center CV Research NYU Langone Medical Center New York New York 10016 United States Details
Genesis Cancer Services SC Zanesville Ohio 43701 United States Details
Penn State University Milton S Hershey Medical Center SC Hershey Pennsylvania 17033 United States Details
Millennium Research Clin Develop SC Houston Texas 77090 United States Details
Northern Utah Cancer Associates CFTY720DUS01 Ogden Utah 84403-3105 United States Details
Providence Regional Cancer Partnership . Everett Washington 98201 United States Details
Providence Regional Cancer System SC Lacey Washington 98503 United States Details
Virginia Mason Medical Center-Oncology SC Seattle Washington 98101 United States Details
Novartis Investigative Site St Leonards New South Wales 2065 Australia Details
Novartis Investigative Site Herston Queensland 4029 Australia Details
Novartis Investigative Site East Melbourne Victoria 3002 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Vienna A-1100 Austria Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Aalst 9300 Belgium Details
Novartis Investigative Site Charleroi 6000 Belgium Details
Novartis Investigative Site Hasselt 3500 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Sofia 1606 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Surrey British Columbia V3V 1Z2 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Victoria British Columbia V8R 6V5 Canada Details
Novartis Investigative Site Moncton New Brunswick E1C 8X3 Canada Details
Novartis Investigative Site Halifax Nova Scotia B3H 1V7 Canada Details
Novartis Investigative Site Brampton Ontario L6R 3J7 Canada Details
Novartis Investigative Site Kingston Ontario K7L 5P9 Canada Details
Novartis Investigative Site Newmarket Ontario J7Y 2P9 Canada Details
Novartis Investigative Site Montreal Quebec H3G 1L5 Canada Details
Novartis Investigative Site Rimouski Quebec G5L 5T1 Canada Details
Novartis Investigative Site Sherbrooke Quebec J1H 5N4 Canada Details
Novartis Investigative Site Trois Rivieres Quebec G8Z 3R9 Canada Details
Novartis Investigative Site Bogota 110221 Colombia Details
Novartis Investigative Site Monteria 230004 Colombia Details
Novartis Investigative Site Brno Bohunice Czech Republic 625 00 Czechia Details
Novartis Investigative Site Liberec Czech Republic 46063 Czechia Details
Novartis Investigative Site Brno 65653 Czechia Details
Novartis Investigative Site Prague 8 180 81 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Aalborg DK 9000 Denmark Details
Novartis Investigative Site Aarhus DK-8000 Denmark Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Herlev 2730 Denmark Details
Novartis Investigative Site Odense C DK 5000 Denmark Details
Novartis Investigative Site Vejle 7100 Denmark Details
Novartis Investigative Site Strasbourg Cedex 67000 France Details
Novartis Investigative Site Saint-Cloud Hauts De Seine 92210 France Details
Novartis Investigative Site Reims Marne 51056 France Details
Novartis Investigative Site Besancon Cedex 25030 France Details
Novartis Investigative Site Bordeaux Cedex 33000 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Brest 29200 France Details
Novartis Investigative Site Creteil 94000 France Details
Novartis Investigative Site Le Mans Cedex 72015 France Details
Novartis Investigative Site Lille Cedex 59020 France Details
Novartis Investigative Site Limoges 87000 France Details
Novartis Investigative Site Paris 13 75651 France Details
Novartis Investigative Site Pierre Benite 69495 France Details
Novartis Investigative Site Toulon La Seyne Sur Mer 83056 France Details
Novartis Investigative Site Langen Hessen 63225 Germany Details
Novartis Investigative Site Georgsmarienhuette Lower Saxony 49124 Germany Details
Novartis Investigative Site Augsburg 86150 Germany Details
Novartis Investigative Site Berlin 10117 Germany Details
Novartis Investigative Site Berlin 10967 Germany Details
Novartis Investigative Site Bielefeld 33604 Germany Details
Novartis Investigative Site Bonn 53111 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Fuerth 90766 Germany Details
Novartis Investigative Site Hamburg 22081 Germany Details
Novartis Investigative Site Hamburg 22767 Germany Details
Novartis Investigative Site Hannover 30559 Germany Details
Novartis Investigative Site Heidelberg 69115 Germany Details
Novartis Investigative Site Koeln 50935 Germany Details
Novartis Investigative Site Luebeck 23538 Germany Details
Novartis Investigative Site Muenchen 80637 Germany Details
Novartis Investigative Site Mühlhausen 99974 Germany Details
Novartis Investigative Site Oldenburg 26121 Germany Details
Novartis Investigative Site Ravensburg 88214 Germany Details
Novartis Investigative Site Saarbruecken 66113 Germany Details
Novartis Investigative Site Troisdorf 53840 Germany Details
Novartis Investigative Site Tuebingen 72076 Germany Details
Novartis Investigative Site Velbert 42551 Germany Details
Novartis Investigative Site Weiden 92637 Germany Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Budapest H-1032 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site L'Aquila AQ 67100 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Catania CT 95124 Italy Details
Novartis Investigative Site Lecce LE 73100 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Pontedera PI 56025 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut 1107 2020 Lebanon Details
Novartis Investigative Site Johor Bahru Johor 81100 Malaysia Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Oaxaca 68000 Mexico Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Breda 4819 EV Netherlands Details
Novartis Investigative Site Den Haag 2545 CH Netherlands Details
Novartis Investigative Site Deventer 7416 SE Netherlands Details
Novartis Investigative Site Enschede 7513 ER Netherlands Details
Novartis Investigative Site Groningen 9728 NZ Netherlands Details
Novartis Investigative Site Hoofddorp 2134 TM Netherlands Details
Novartis Investigative Site Maastricht 6229 HX Netherlands Details
Novartis Investigative Site Nieuwegein 3435 CM Netherlands Details
Novartis Investigative Site Roermond 6043 CV Netherlands Details
Novartis Investigative Site Sittard-Geleen 6162 BG Netherlands Details
Novartis Investigative Site Tilburg 5042 AD Netherlands Details
Novartis Investigative Site Oslo NO 0424 Norway Details
Novartis Investigative Site Konin 62 500 Poland Details
Novartis Investigative Site Warszawa 04-125 Poland Details
Novartis Investigative Site Lisboa 1400-038 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Tambov 392000 Russian Federation Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Granada Andalucia 18014 Spain Details
Novartis Investigative Site Madrid Andalucia 28046 Spain Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Sevilla Andalucia 41014 Spain Details
Novartis Investigative Site Sant Joan Despi Barcelona 08970 Spain Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site A Coruna Galicia 15009 Spain Details
Novartis Investigative Site Alcorcon Madrid 28922 Spain Details
Novartis Investigative Site San Sebastian de los Reyes Madrid 28702 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Eskilstuna SE-631 88 Sweden Details
Novartis Investigative Site Sundsvall 851 86 Sweden Details
Novartis Investigative Site Vaxjo SE-351 85 Sweden Details
Novartis Investigative Site Aarau 5000 Switzerland Details
Novartis Investigative Site Basel 4031 Switzerland Details
Novartis Investigative Site Zuerich 8038 Switzerland Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Istanbul 34303 Turkey Details
Novartis Investigative Site Istanbul 34381 Turkey Details
Novartis Investigative Site Istanbul 34662 Turkey Details
Novartis Investigative Site Izmir 35575 Turkey Details
Novartis Investigative Site Plymouth Devon PL6 8DH United Kingdom Details
Novartis Investigative Site Newcastle Upon Tyne NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field